Merck Wants to Extend RSV Vaccine to Second Season
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
CVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.
California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.